Theonila Roka Matbob, a Goldman Prize winner, emphasizes the role of women as guardians of the land while addressing the damage caused by mining in Papua New Guinea.
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
On the 10th anniversary of Victoria Wood's death, friends and fans reflect on her remarkable talent and the impact she had on the world of comedy.
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Early retirement at 62 can be appealing, but it comes with significant financial considerations, including a $47,000 healthcare gap before Medicare starts.
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
As school choice initiatives gain traction in Iowa and nationwide, Cedar Rapids serves as a case study on the potential impacts of market-driven education.
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.
A recent study highlights a notable decline in hospital utilization in Maryland, showing an 11 percentage point decrease compared to other states from 2013 to 2023.
A recent analysis highlights the trends in national spending on mental health and substance use disorder treatment from 2000 to 2021, reflecting case growth over the years.
The pancreatic cancer drug Daraxonrasib from Revolution Medicines is reportedly achieving remarkable results, with some patients experiencing doubled survival times.
In a recent directive, Trump has called on federal agencies to expedite access to psychedelic treatments and reconsider their classification as controlled substances.
The podcast 'Why Should I Trust You?' emphasizes the need for communication between MAHA and public health, highlighting the stakes involved.
While there is a sense of optimism regarding Trump's choice for the CDC, employees express a cautious outlook, especially concerning RFK Jr.'s involvement.
As the 2026 Stanley Cup playoffs approach, anticipation builds. Fans eagerly await to see which of the 16 competing teams will claim the coveted title.
A recent analysis reveals trends in employer-based health insurance, affecting 165.6 million individuals under 65 years old as of March 2025.